A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic
黏蛋白-1 还原化合物的高内涵筛选确定 Fostamatinib 是可在 COVID-19 大流行期间快速用于治疗急性肺损伤的候选药物
期刊:
影响因子:
doi:10.1101/2020.06.30.180380
Maria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, Moran Dvela-Levitt, Michelle Melanson, Brian T Chamberlain, Seth L Alper, Jean Santos, Juan Gutierrez, Ayshwarya Subramanian, Elizabeth Grinkevich, Estefania Reyes Bricio, Choah Kim, Abbe Clark, Andrew Watts, Rebecca Thompson, Jamie Marshall, Juan